Items Tagged ‘Dr. Liewei Wang’
August 22, 2017
By Sharon Rosen 
New genomic technologies and discoveries are transforming medical care in ways that we have yet to fully understand. It’s no longer business as usual. Physicians are seeing new approaches to many aspects of daily medical care, such as ordering genetic tests, choosing pain management therapies or prescribing medications. For example, both physicians and patients may […]
Tags: #CIMCon17, #Dr. Amy Lemke, #Dr. David Bick, #Dr. Donald Basel, #Dr. James Liu, #Dr. Robert Green, #Dr. Susanne Haga, #Dr. Wendy van Zelst-Stams, #Dr. William Mauck, #Individualizing Medicine 2017, #pain management, #rare genetic diseases
July 3, 2017
Trying to quit smoking? Genetics may help find the right plan for success
By Sharon Rosen
After trying different methods, why do many people have difficulty quitting smoking? That’s a question Rachel Tyndale, Ph.D., is asking as part of her research into smoking cessation therapy. As senior scientist and head of the Pharmacogenetics Lab in the Campbell Family Mental Health Research Institute at University of Toronto, Dr. Tyndale is using molecular […]
Tags: #CIMCon17, #DNA analysis, #Dr. J. Steven Leeder, #Dr. Rachel Tyndale, #drug-gene reactions, #Individualizing Medicine 2017, #preemptive pharmacogenomics, #smoking cessation, center for individualized medicine, DNA Sequencing, Dr. Eric Matey, Dr. Liewei Wang
June 30, 2017
Pharmacogenomics – striving for safer, more effective drugs for you
By Sharon Rosen
At Mayo Clinic, pharmacogenomics – how your genes impact the way you process medications – is helping doctors to take the guess work out of selecting safer, more effective treatment for patients. Mayo researchers have been leaders in developing DNA tests and identifying drug-gene interactions that affect a patient’s response to many medications, such as […]
Tags: #CIMCon17, #drug safety, #drug-gene reactions, #Karen Daggett, center for individualized medicine, Dr. Eric Matey, Dr. Liewei Wang, Dr. Richard Weinshilboum, Heart Disease, mayo clinic, Mayo Clinic Pharmacogenomics Program, medical research
February 14, 2017
Mayo Clinic physician-researchers selected for medical research society
By Sharon Rosen
Article by Susan Buckles, Public Affairs Liewei Wang, M.D., Ph.D. is one of two Mayo Clinic physician-researchers named to one of America’s oldest and most prestigious medical honor societies. Dr. Wang, co-director of the Center for Individualized Medicine Pharmacogenomics program and Martin E. Fernandez-Zapico, M.D., a pancreatic cancer biologist, have been inducted into The American […]
Tags: #American Society of Clinical Investigation, #ASCI, #cancer biology, #disease-oriented research, #Dr. Martin Fernandez-Zapico, center for individualized medicine, Dr. Liewei Wang, mayo clinic, medical research, pharmacogenomics, Precision Medicine
November 10, 2016
By Sharon Rosen
One size does not fit all – especially when it comes to medications. Pharmacogenomics is the study of how your individual genetic characteristics impact your response to medications. The RIGHT study, done at Mayo Clinic, found that 99 percent of people studied had a genetic variation that affects how they respond to a drug therapy. […]
Tags: #Dr. Robert Freimuth, #drug-gene reactions, #Genetic data, #PrecisionMedicine, #RIGHT 10K study, center for individualized medicine, Dr. Liewei Wang, Dr. Richard Weinshilboum, mayo clinic, PGx, pharmacogenomics
August 30, 2016
Meeting the Genomic Data Challenge: New Collaboration Speeds Precision Medicine Discovery
By Sharon Rosen
Each of us has a unique genetic makeup of more than three billion molecules that are the building blocks for our DNA. These building blocks create the blueprint for everything from our eye color to how our body functions, how we process medications and how likely we are to contract disease. Because of today’s DNA […]
Tags: #Big Data to Knowledge Grant, #Dr. Ravi Iyer, #Genomic data, center for individualized medicine, DNA Sequencing, Dr. Liewei Wang, mayo clinic, University of Illinois at Urbana-Champaign
July 7, 2016
Mayo Clinic Researcher Receives Distinguished Award for Pharmacogenomics Research
By Sharon Rosen
Liewei Wang, M.D., Ph.D., Mayo Clinic professor of Pharmacology, received the highly prestigious Leon I. Goldberg Early Investigator Award for her pharmacogenomics research. Pharmacogenomics is the study of how a patient’s genes affect the body’s response to medication. She is the second Mayo Clinic faculty member to have received the award by the American Society for […]
Tags: American Society for Clinical Pharmacology and Therapeutics, biomarkers, center for individualized medicine, Dr. James Ingle, Dr. Judy Boughey, Dr. Liewei Wang, Dr. Matthew Goetz, Dr. Richard Weinshilboum, Leon I. Goldberg Early Investigator Award, mayo clinic, Mayo Clinic Center for Individualized Medicine, pharmacogenomics